COVID-19 and Type 1 Diabetes: Concerns and Challenges COVID19 and T1D

Main Article Content

Lorenzo Iughetti
Viola Trevisani
Umberto Cattini
Patrizia Bruzzi
Laura Lucaccioni
Simona Madeo
Barbara Predieri

Keywords

COVID19,, Children, Telemedicine, Type 1 Diabetes

Abstract

Due to the current COVID-19 pandemic, worldwide population’s lifestyle has changed dramatically, causing psychosocial consequences.  Patients presenting a preexisting chronic condition, as Type 1 Diabetes (T1D), are the ones suffering the most from this situation. Moreover, people affected by diabetes are the ones with the worst prognosis, if infected by SARS-CoV-2.  We analyzed why patients with T1D were poorly represented between the subjects hospitalized for COVID-19 and why the cases of diabetic ketoacidosis (DKA) were fewer and more severe compared with the past years. Furthermore, literature has showed how patients of all ages with T1D did not experience a deterioration in their glucose control throughout the lockdown. Among other causes, this is also due to the surging use of telemedicine. Finally, we tried to understand how the coronavirus tropism for endocrine tissues could influence the future epidemiology of T1D, focusing on the effects they have on pancreatic β-cells.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...
Abstract 129 | PDF Downloads 95

References

 Statement on the second meetting of the International Health Regulations (200%) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). World Health Organozation (WHO) (Press release). 30th Janaury 2020. Archived from the original on 31st January 2020. Retrieved 30th January 2020. https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov) last access July 30, 2020
 WHO Director-General’s opening remarks at the briefing on COVID-19 – 11th March 2020. World Health Organization (WHO) (press release). 11th March 2020. Archieved from the original on 11th March 2020. Retrieved 12th March 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 last access July 30, 2020
 Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2020. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2020.
 Selvin E, Juraschek SP. Diabetes Epidemiology in the COBID-19 Pandemic. Diabetes Care, 2020; 43(8):1690–1694.
Apicella M, Campopiano MC, Mantuano M, Mazoni L, Coppelli A, Del Prato S. COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol. 2020 Sept;8(9):782-792
Huang I, Lim MA, Pranata R. Diabtetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia e A systematic review, meta analysis, and meta-regression. Diabetes Metab Syndr 2020; 14:395-403
 Barron E, Bakhai C, Kar P et al. Type 1 and Type 2 diabetes and COVID-19 related mortality in England: a whole population study. https://www.england.nhs.uk/wp-content/uploads/2020/05/Valabhji-COVID-19-and-Diabetes-Paper-2-Full-Manuscript.pdf
 Pitocco D, Tartaglione L, Viti L et al. Lack of Type 1 Diabetes involvement in SARS-CoV-2 population: Only a particular coincidence? Diabetes Res Clin Pract. 2020; 164:108220
 Bronson SC. Letter to the Editor in response to the article “Lack of Type 1 Diabetes involvement in the SARS-CoV-2 population: Only a particular coincidence?”. Diabetes Res Clin Pract, 2020; 3:108306
Tatti P, Tonolo G, Zanfardino A, Iafusco D. Letter to the Editor: CoVid-19 and Type 1 Diabetes: Every cloud has a silver lining. Searching the reason of a lower aggressiveness of the CoronaVirus disease in Type 1 Diabetes. Diabetes Res Clin Pract. 2020 Jun 12:108270. doi: 10.1016/j.diabres.2020.108270. Online ahead of print
Tatti P, Tonolo G, Zanfardino A, Iafusco D. Is it fair that patients with Type 1 Diabetes (autoimmune) may be spared by the infection of Covid-19? Medical Hypothesis 2020;14: 109795
Fallahi P, Ferrari SM, Ragusa F et al. Th1 chemokines in autoimmune endocrine disorders. J Clin Endocrinol Metab 2020;105(4):dgz289. doi: 10.1210/clinem/dgz289
Yang JK, Lin SS, Ji XJ, Guo LM. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol. 2010;47:193–199.
Yang L, Han Y, Nilsson-Payant BE, et al. A human pluripotent stem cell-based platform to study SARS-CoV-2 tropism and model virus infection in human cells and organoids. Cell Stem Cell 2020; 27(1):125–136.e7
Rabbone I, Schiaffini R, Cherubini V et al. Has COVID-19 delayed the diagnosis and worsened the presentation of typer 1 diabetes in children? Diabetes Care, 2020 Online Ahead of Print
Cella A, Marchetti F, Iughetti L et al. Italian COVID-19 epidemic: effects on paediatric emergency attendance—a survey in the Emilia Romagna region. FREE BMJ Paediatrics Open 2020, 4 (1) e000742
Ebekozien OA, Noor N, Gallagher MP , Todd Alonso G. Type 1 Diabetes and COVID-19: preliminary findings from a multicenter surveillance study in the U.S. Diabetes Care, 2020; 43(8):e83–e85
Potier L, Julla JB, Roussel R et al. COVID-19 symptoms masking inaugural ketoacidosis of Type 1 Diabetes. Diabetes Metab, 2020; S1262–3636(20)30081
Buonsenso D, Onesimo R, Valentini P et al. Children’s healthcare during corona virus disease 19 Pandemic: the Italian Experience. Pediatr Infect Dis J. 2020; 39:e137–40.
Wang C, Pan R, Wan X et al. Immediate psychosocial responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China. Int J Environ Res Public Health 2020; 17(5)–1729
Bonora BM, Boscari F, Avogaro A. Glycaemic control among people with Type 1 Diabetes during lockdown for the SARS-CoV-2 outbreak in Italy. Diabetes Ther, 2020, 11:1369–1379
Beato-Vibora PI. No deleterious effect of lockdown due to COVID-19 pandemic on glycaemic control, measured by glucose monitoring, in adults with Ttype 1 diabetes. Diabetes Technology and Therapeutics, 2020. DOI: 10.1089
Schiaffini R, Barbetti F, Rapini N et al. School and pre-school children with Type 1 Diabetes during COVID-19 quarantine: the synergic effect of parental control and technology. Diabetes Res Clin Pract, 2020;108302
Tornese G, Ceconi V, Monasta L , Carletti C, Faleschini E, Barbi E. Glycemic control in Type 1 Diabetes mellitus during COVID-19 quarantine and the role of in-home physical activity. Diabetes Tech and Therap, 2020; 22:6.
Passanisi S, Pecoraro M, Pira F et al. Quarantine due to the COVID-19 pandemic from the perspective of pediatric patients with Type 1 Diabetes: a web-based survey. Frontiers in Pediatrics, 2020; 8:491
Peluso MA, Guerra de Andrade LH. Physical activity and mental health: the association between exercise and mood. Clinics (Sao Paulo) 2005; 60:61–70
Wagner DV, Barry SA, Stoeckel M et al. NICH at its best for diabetes at its worst: texting teens and their caregivers for better outcomes. J Diabetes Sci Technol, 2017;11:468–475
McDonnel ME. Telemedicine in complex diabetes management. Curr Diab Rep. 2018; 18:42
Ziegler R. Challenges in the Care of Children and Youth With Diabetes in Times of the Corona Pandemic: Personal View of the Situation in a German Clinic. J Diabetes Sci Technol. 2020;14:811–812.
Lönnrot M, Lynch KF, Elding Larsson H et al. Respiratory infections are temporally associated with initiation of Type 1 Diabetes autoimmunity: the TEDDY study. Diabetologia 2017; 60:1931–40
Op de Beeck A, Eizirik DL. Viral infections in Type 1 Diabetes mellitus-why the β cells? Nat Rev Endocrinol 2016;12:263–73
Bindom SM, Lazartigues E. The sweeter side of ACE2: physiological evidence for a role in diabetes. Mol Cell Endocrinol 2009; 302: 193–202
Marchand L, Pecquet M, Luyton C. Type 1 Diabetes onset triggered by COVID‑19. Acta Diabetol. 2020; 11:1–2.
Caruso P, Longo M, Esposito K, Maiorino MI. Type 1 Diabetes triggered by covid-19 pandemic: A potential outbreak. Diab Res and Clin Pract, 2020; 164:108219